Views & Analysis UK pharma in 2017: NHS funding, a legal challenge and Brexit The UK pharma industry added its voice to calls for greater NHS funding in 2017 – but Brexit guaranteed there could be no rescue package
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends